Pubblicazioni scientifiche sui diagnostici non invasivi BioPredictive

Studi sottoposti a revisione paritaria che convalidano i diagnostici ematici BioPredictive per le malattie del fegato — dalle coorti di sviluppo pionieristiche alle meta-analisi a lungo termine.

4/435 Risultati per
“NNS, needed to screen”

“NNS, needed to screen” Cancella tutto

  1. External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B. Key publication

    Poynard T et al. · Gastro Hep Adv · 2022 Punteggio 100

    …A post hoc analysis compared the number of patients needed to screen…

    FibroTest LCR1 LCR2 HBV

  2. External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV. Key publication

    Poynard T et al. · JHEP Rep · 2021 Punteggio 88

    …The aim was to externally validate the LCR1-LCR2 in patients with…

    LCR1 LCR2 HCV

  3. LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis. Key publication

    Poynard T et al. · Aliment Pharmacol Ther · 2019 Punteggio 75

    …that is 12 patients needed to screen one cancer. The negative predictive…

    LCR1 LCR2 Alcohol HBV +4

  4. Peta V, Ziol M, Imbert-Bismut F, et al., for the FibroFrance-GHPS-HECAM group

    Valentina Peta et al. · GastroHep · 2019 Punteggio 63

    FibroTest LCR1 LCR2 Alcohol +3

Mostra l'elenco completo dei risultati. La pagina è renderizzata sul server e non è paginata.